Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis.

Gerling M, Nousiainen K, Hautaniemi S, Krüger S, Fritzsche B, Homann N, Bruch HP, Auer G, Roblick UJ, Ried T, Habermann JK.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):691-703. doi: 10.1097/MIB.0b013e31827eeaa4.

PMID:
23455720
2.

Aneuploidy characterizes adjacent non-malignant mucosa of ulcerative colitis-associated but not sporadic colorectal carcinomas: a matched-pair analysis.

Meyer KF, Nause SL, Freitag-Wolf S, Krüger S, Bruch HP, Roblick UJ, Habermann JK.

Scand J Gastroenterol. 2013 Jun;48(6):679-87. doi: 10.3109/00365521.2013.783103. Epub 2013 Apr 2.

PMID:
23544594
3.
5.

Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.

Kuester D, Guenther T, Biesold S, Hartmann A, Bataille F, Ruemmele P, Peters B, Meyer F, Schubert D, Bohr UR, Malfertheiner P, Lippert H, Silver AR, Roessner A, Schneider-Stock R.

Pathol Res Pract. 2010 Sep 15;206(9):616-24. doi: 10.1016/j.prp.2010.05.004. Epub 2010 Jul 13.

PMID:
20630662
6.

Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.

Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, Ordás I, Esteller M, Ricart E, Piqué JM, Panés J, Salas A.

Gut. 2013 Jul;62(7):967-76. doi: 10.1136/gutjnl-2012-303333. Epub 2012 Nov 7.

PMID:
23135761
7.

DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study.

Befrits R, Hammarberg C, Rubio C, Jaramillo E, Tribukait B.

Dis Colon Rectum. 1994 Apr;37(4):313-9; discussion 319-20.

PMID:
8168409
8.

Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia.

Bjerrum JT, Nielsen OH, Riis LB, Pittet V, Mueller C, Rogler G, Olsen J.

Inflamm Bowel Dis. 2014 Dec;20(12):2340-52. doi: 10.1097/MIB.0000000000000235.

PMID:
25358065
9.

Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer.

Levine DS, Rabinovitch PS, Haggitt RC, Blount PL, Dean PJ, Rubin CE, Reid BJ.

Gastroenterology. 1991 Nov;101(5):1198-210.

PMID:
1936790
10.

Molecular profiling of ulcerative colitis-associated neoplastic progression.

Colliver DW, Crawford NP, Eichenberger MR, Zacharius W, Petras RE, Stromberg AJ, Galandiuk S.

Exp Mol Pathol. 2006 Feb;80(1):1-10. Epub 2005 Nov 8.

PMID:
16277983
11.

Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.

Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.

Am J Gastroenterol. 1997 Nov;92(11):2001-6.

PMID:
9362180
12.

Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis.

Burum-Auensen E, Deangelis PM, Schjølberg AR, Røislien J, Andersen SN, Clausen OP.

J Clin Pathol. 2007 Dec;60(12):1403-8. Epub 2007 Feb 23.

13.

Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis.

Watanabe T, Kobunai T, Yamamoto Y, Ikeuchi H, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Kanazawa T, Tanaka T, Yokoyama T, Konishi T, Eshima K, Ajioka Y, Hibi T, Watanabe M, Muto T, Nagawa H.

Clin Colorectal Cancer. 2011 Jun;10(2):134-41. doi: 10.1016/j.clcc.2011.03.011. Epub 2011 Apr 22.

PMID:
21859567
14.

Mucosal transcriptomics implicates under expression of BRINP3 in the pathogenesis of ulcerative colitis.

Smith PJ, Levine AP, Dunne J, Guilhamon P, Turmaine M, Sewell GW, OʼShea NR, Vega R, Paterson JC, Oukrif D, Beck S, Bloom SL, Novelli M, Rodriguez-Justo M, Smith AM, Segal AW.

Inflamm Bowel Dis. 2014 Oct;20(10):1802-12. doi: 10.1097/MIB.0000000000000169. Erratum in: Inflamm Bowel Dis. 2015 Apr;21(4):911. Inflamm Bowel Dis. 2016 Feb;22(2):E10.

15.

Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4-NFκB signalling.

Scarpa M, Cardin R, Bortolami M, Kotsafti A, Scarpa MC, Pozza A, Maran G, Picciocchi M, Ruffolo C, D'Incà R, Sturniolo GC, Castagliuolo I, Castoro C, Angriman I.

Eur J Cancer. 2013 Jan;49(1):254-63. doi: 10.1016/j.ejca.2012.05.015. Epub 2012 Jun 14.

PMID:
22704122
16.

Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment.

Habermann J, Lenander C, Roblick UJ, Krüger S, Ludwig D, Alaiya A, Freitag S, Dümbgen L, Bruch HP, Stange E, Salo S, Tryggvason K, Auer G, Schimmelpenning H.

Scand J Gastroenterol. 2001 Jul;36(7):751-8.

PMID:
11444475
17.

Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.

Toedter G, Li K, Sague S, Ma K, Marano C, Macoritto M, Park J, Deehan R, Matthews A, Wu GD, Lewis JD, Arijs I, Rutgeerts P, Baribaud F.

Inflamm Bowel Dis. 2012 Aug;18(8):1399-410. doi: 10.1002/ibd.22853. Epub 2012 Jan 4.

PMID:
22223479
18.

Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis.

van Dieren JM, Wink JC, Vissers KJ, van Marion R, Hoogmans MM, Dinjens WN, Schouten WR, Tanke HJ, Szuhai K, Kuipers EJ, van der Woude CJ, van Dekken H.

Diagn Mol Pathol. 2006 Dec;15(4):216-22.

PMID:
17122649
19.

DNA aneuploidy in ulcerative colitis.

Fozard JB, Quirke P, Dixon MF, Giles GR, Bird CC.

Gut. 1986 Dec;27(12):1414-8.

20.

Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.

Gushima M, Hirahashi M, Matsumoto T, Fujita K, Ohuchida K, Oda Y, Yao T, Iida M, Tsuneyoshi M.

Histopathology. 2011 Sep;59(3):460-9. doi: 10.1111/j.1365-2559.2011.03965.x.

PMID:
22034886

Supplemental Content

Support Center